Kidney neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients aged 18-65 years scheduled for elective laparoscopic nephrectomy; 2) ASA I-III; 3) Willing to participate in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: 1) allergy to local anesthetics; 2) BMI > 35 kg/m2; 3) history of mental illness or taking psychotropic drugs; 4) combined with spinal deformity; 5) long-term use of analgesics or sedatives; 6) history of drug abuse, alcohol or opioid abuse; 7) chronic pain or recent acute pain; 8) severe liver and kidney dysfunction; 9) any reason can not cooperate with the study or researchers think it is not suitable for inclusion in this trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the total use of sufentanil during intraoperative period; | — |
Secondary
| Measure | Time frame |
|---|---|
| intraoperative remifentanil consumption;VAS pain scores at rest and coughing at 1 hour, 6 hours, 12 hours, 24 hours, 48 hours after surgery;incidence of nausea and vomiting in the first 24 hour after surgery;times of rescue analgesic; | — |
Countries
China
Contacts
Department of Anesthesiology, Second Affiliated Hospital of Army Medical University